← Leaderboards
Stuart Alexander Scott
Stanford University
$1,277,840
Attributed
$2,277,840
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–23$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,277,840 · 2
By mechanism
U24$1,500,000 · 1
K23$777,840 · 1
Top collaborators
- Teri Ellen Klein1 shared
- Michelle Whirl-Carrillo1 shared
Most similar at Stanford University
Same institution · by research overlap
- Teri Ellen Klein$27,775,851
- Gregory S. Barsh$28,951,512
- Paul Po Sheng Cheng$2,095,794
- Kelly McGowan$504,390
- Yvonne A. Maldonado$6,555,051
Others in their field
Top investigators on “Pharmacogenetics”
- Richard L Schilsky · University Of Chicago$84,553,000
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Russ Biagio Altman · University Of California San Francisco$42,267,633
- Richard M Weinshilboum · Mayo Clinic Coll Of Medicine, Rochester$40,766,671
- Dan M Roden · Vanderbilt University Medical Center$40,676,144
- Scott T Weiss · University Of California, San Diego$39,481,472
Research focus
PharmacogeneticsTraitGeneticPharmacodynamicsResearch PersonnelStandard Of CareDrug KineticsGenesHuman GeneticsPharmaceutical PreparationsPhenotypeProgramsResourcesResponseClinical ResearchCollaborationsEnvironmentFundingBasic ScienceGenomicsLaboratoriesMolecularPharmacogenomicsTranslational Research
Grant awards (5)
PharmGKB$1,500,000
U24 · FY2023 · HG
The Pharmacogenomic Control of Clopidogrel Response in Acute Coronary Syndromes$194,460
K23 · FY2016 · GM · contact PI
The Pharmacogenomic Control of Clopidogrel Response in Acute Coronary Syndromes$194,460
K23 · FY2015 · GM · contact PI
The Pharmacogenomic Control of Clopidogrel Response in Acute Coronary Syndromes$194,460
K23 · FY2014 · GM · contact PI
The Pharmacogenomic Control of Clopidogrel Response in Acute Coronary Syndromes$194,460
K23 · FY2013 · GM · contact PI